Terms: = Germ cell tumor AND KLF6, RP11-184A2_1, 1316, ENSG00000067082, ST12, DKFZp686N0199, CPBP, Zf9, COPEB, ZF9, PAC1, GBF, BCD1
99010 results:
1. Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel cell Carcinoma: a systematic review and Meta-analysis.
de Moraes FCA; Kreuz M; de Lara ICA; Lôbo AOM; Burbano RMR
BMC Cancer; 2024 Nov; 24(1):1357. PubMed ID: 39506680
[TBL] [Abstract] [Full Text] [Related]
2. Random survival forest algorithm for risk stratification and survival prediction in gastric neuroendocrine neoplasms.
Liao T; Su T; Lu Y; Huang L; Wei WY; Feng LH
Sci Rep; 2024 Nov; 14(1):26969. PubMed ID: 39506090
[TBL] [Abstract] [Full Text] [Related]
3. [Significance of the preferentially expressed antigen in melanoma in discriminating the conjunctival malignant melanoma and pigmented nevus].
Tang LJ; Chen SX; Gao HH; Zhang WX; Lin JX; Zhang P
Zhonghua Yan Ke Za Zhi; 2024 Nov; 60(11):887-891. PubMed ID: 39505373
[No Abstract] [Full Text] [Related]
4. TME-Activated MnO
Chen L; Liu M; Wang Y; Wei W; Li Y; Bai Y; Yu X; Jiao L; Wang M
Int J Nanomedicine; 2024; 19():11055-11070. PubMed ID: 39502635
[TBL] [Abstract] [Full Text] [Related]
5. Revealing the structural microenvironment of high metastatic risk uveal melanomas following decellularisation.
Aughton K; Hattersley J; Coupland SE; Kalirai H
Sci Rep; 2024 Nov; 14(1):26811. PubMed ID: 39500968
[TBL] [Abstract] [Full Text] [Related]
6. Challenges and predictive radiological findings in the diagnosis of neuroendocrine tumors in patients with acute appendicitis.
Şimşek O; Şirolu S; Özkan Irmak Y; Hamid R; Ergun S; Kepil N; Tutar O
Ulus Travma Acil Cerrahi Derg; 2024 Nov; 30(11):780-785. PubMed ID: 39498711
[TBL] [Abstract] [Full Text] [Related]
7. A co-culture model to study modulators of tumor immune evasion through scalable arrayed CRISPR-interference screens.
Martinez R; Finocchiaro C; Delhaye L; Gysens F; Anckaert J; Trypsteen W; Versteven M; Lion E; Van Lint S; Vermaelen K; de Bony EJ; Mestdagh P
Front Immunol; 2024; 15():1444886. PubMed ID: 39497819
[TBL] [Abstract] [Full Text] [Related]
8. Atypical chemokine receptor 2 expression is directly regulated by hypoxia inducible factor-1 alpha in cancer cells under hypoxia.
Benoit A; Lequeux A; Harter P; Berchem G; Janji B
Sci Rep; 2024 Nov; 14(1):26589. PubMed ID: 39496762
[TBL] [Abstract] [Full Text] [Related]
9. Lnc NEAT1 facilitates the progression of melanoma by targeting the miR-152-3p/CDK6 axis: An observational study.
Ning N; Tian Z; Feng H; Feng X
Medicine (Baltimore); 2024 Nov; 103(44):e40379. PubMed ID: 39495991
[TBL] [Abstract] [Full Text] [Related]
10. Primary intracranial malignant melanomas: A case series with literature review.
Chen L; Yang Y; Li D; Bu B
Medicine (Baltimore); 2024 Nov; 103(44):e40334. PubMed ID: 39495986
[TBL] [Abstract] [Full Text] [Related]
11. Gadoxetic acid-enhanced MRI for the detection of liver metastases from melanoma.
Chung HJ; Seo N; Han K; Bae H; Chung YE; Jung M; Park MS
PLoS One; 2024; 19(11):e0313212. PubMed ID: 39495777
[TBL] [Abstract] [Full Text] [Related]
12. Treatment of Conjunctival Melanoma cell Lines With a Light-Activated Virus-Like Drug Conjugate Induces Immunogenic cell Death.
Ma S; Huis In't Veld RV; de Los Pinos E; Ossendorp FA; Jager MJ
Invest Ophthalmol Vis Sci; 2024 Nov; 65(13):3. PubMed ID: 39495183
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review.
Ou Y; Liang S; Gao Q; Shang Y; Liang J; Zhang W; Liu S
Front Immunol; 2024; 15():1482746. PubMed ID: 39493767
[TBL] [Abstract] [Full Text] [Related]
14. A case report on lingual schwannoma.
Ramyead DP; Enslin J; Chokoe Maluleke MJ; White M
S Afr J Surg; 2024 Oct; 62(3):54-57. PubMed ID: 39491965
[TBL] [Abstract] [Full Text] [Related]
15. Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME.
de Freitas JT; Thakur V; LaPorte KM; Thakur VS; Flores B; Caicedo V; Ajaegbu CGE; Ingrasci G; Lipman ZM; Zhang K; Qiu H; Malek TR; Bedogni B
J Exp Clin Cancer Res; 2024 Nov; 43(1):295. PubMed ID: 39491031
[TBL] [Abstract] [Full Text] [Related]
16. First-in-human, phase 1 dose-escalation and dose-expansion study of a RET inhibitor SY-5007 in patients with advanced RET-altered solid tumors.
Li W; Wang Y; Xiong A; Gao G; Song Z; Zhang Y; Huang D; Ye F; Wang Q; Li Z; Liu J; Xu C; Sun Y; Liu X; Zhou F; Zhou C
Signal Transduct Target Ther; 2024 Nov; 9(1):300. PubMed ID: 39489747
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic nomogram model based on quantitative metrics of subregions surrounding residual cavity in glioblastoma patients.
Gao L; Yuan T; Liu Y; Yang X; Li Y; Quan G
J Cancer Res Clin Oncol; 2024 Nov; 150(11):483. PubMed ID: 39487262
[TBL] [Abstract] [Full Text] [Related]
18. TSH enhances neurite outgrowth.
Mansoori M; Latif R; Morshed SA; Zaidi M; Davies TF
Front Endocrinol (Lausanne); 2024; 15():1463964. PubMed ID: 39483982
[TBL] [Abstract] [Full Text] [Related]
19. Peptide Receptor Radionuclide Therapy and clinical associations with renal and hematological toxicities and survival in patients with neuroendocrine tumors: an analysis from two U.S. medical centers.
Xu T; Dillon JS; Maluccio MA; Quelle DE; Nash SH; Cho H; Limbach KE; Skill NJ; Bren-Mattison Y; O'Rorke MA
J Cancer Res Clin Oncol; 2024 Nov; 150(11):485. PubMed ID: 39488644
[TBL] [Abstract] [Full Text] [Related]
20. Promoting application of enhanced recovery after surgery protocols during perioperative localized abdominal and thoracic neuroblastomas.
He J; Wang Z; Yu X; Su Y; Hong M; Zhu K
Pediatr Surg Int; 2024 Nov; 40(1):286. PubMed ID: 39487870
[TBL] [Abstract] [Full Text] [Related]
[Next]